Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Anishka D'Souza"'
Autor:
Yun Cheng Sawa, Liwei Jia, Harris Krause, Margaret Meagher, Frederick Millard, Andrew Elliott, John T. Lafin, Christina Jamieson, Emmanuel S. Antonarakis, Anishka D’Souza, Krinio Giannikou, James F. Amatruda, Siamak Daneshmand, Rana R. McKay, Matthew Oberley, Chadi Nabhan, Aditya Bagrodia
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-6 (2024)
Abstract We sought to evaluate the genomic and transcriptomic landscapes in primary and metastatic germ cell tumors (GCTs; N = 138) to uncover factors that drive cisplatin resistance. Prevalence was calculated for platinum-resistant alterations (PRAs
Externí odkaz:
https://doaj.org/article/9c7c3fc28887449ba840d885f022b2bd
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Endocrine therapy has historically formed the basis of treatment of metastatic hormone receptor-positive breast cancer. The development of endocrine resistance has led to the development of newer endocrine drug combinations. Use of the CDK4/
Externí odkaz:
https://doaj.org/article/77e961727f2548b9a29cdac6061d55cd
Autor:
Maedah Veyseh, Charite Ricker, Carin Espenschied, Victoria Raymond, Anishka D’Souza, Afsaneh Barzi
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Liquid biopsies are increasingly used in the care of patients with advanced cancers. These tests are used to find mutations and other genomic alterations, quantify these findings over time, and guide treatment. It is not unexpected that germline muta
Externí odkaz:
https://doaj.org/article/3a0d0f6dbd8d47d88e74c003f97790e3
Autor:
Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, Ananya Roy, Rodolfo Perini, Donna Vickery, Scott S Tykodi
Publikováno v:
The Lancet Oncology. 24:553-562
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36156d0b08238472d6830e2693211f87
https://doi.org/10.1016/s1470-2045(23)00097-9
https://doi.org/10.1016/s1470-2045(23)00097-9
Autor:
Catherine Ly, Shiliang Zhang, Lauren Antrim, Nikhita Kathuria-Prakhash, Matthew Ebia, Varsha Tulpule, Anishka D'souza, Gino Kim In
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-062
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::104033e2a3c8ed22222809e5fcfb7cb9
https://doi.org/10.6004/jnccn.2021.7296
https://doi.org/10.6004/jnccn.2021.7296
Autor:
Peter Zang, Tanya Dorff, Zhang-Xu Liu, Denice Tsao-Wei, Susan Groshen, Cheryl Kefauver, Czarina Patricio, Anishka D'Souza, Sarah Chevalier, Sumanta Pal, Diane DaSilva, Martin Kast, David Quinn
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a75df81cfb75aecbe264bba9201229c3
https://doi.org/10.1136/jitc-2022-sitc2022.0561
https://doi.org/10.1136/jitc-2022-sitc2022.0561
Publikováno v:
Journal of Clinical Oncology. 39:265-268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c6608bdb94fd4e029aae5e35ac8cae
https://doi.org/10.1200/jco.20.03333
https://doi.org/10.1200/jco.20.03333
Autor:
Varsha Tulpule, Irene Kang, Matthew Isaiah Ebia, Charité Ricker, Kimberly A. Miller, Anishka D'souza, Gino K. In, David R. Freyer, Jacob Stephen Thomas, Stephen Capone
Publikováno v:
Cureus
Multiple primary malignancies (MPM) are described as two or more primary tumors within the same individual. The impact of MPM on the tumor microenvironment among patients with melanoma is poorly understood. Here, we describe this unique group of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e35683f7f472dc9e9299abfffb10a535
https://doi.org/10.7759/cureus.15480
https://doi.org/10.7759/cureus.15480
Publikováno v:
Kidney Cancer. 3:93-102
The treatment landscape of advanced renal cell carcinoma (RCC) is rapidly evolving. Immune checkpoint inhibitors (ICI) have now become the preferred first line treatment with the approval of nivolumab and ipilimumab combination in intermediate to poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::530a8bb9ddaa83c385331cd3193752bf
https://doi.org/10.3233/kca-190053
https://doi.org/10.3233/kca-190053
Autor:
Peter Zang, Karen Resnick, Travis Larsen, Shirley Ye, April Choi, Xiao Yu, Kevin Brady, Varsha Tulpule, Anishka D'souza, Gino Kim In
Publikováno v:
Journal of Clinical Oncology. 40:4530-4530
4530 Background: Immune checkpoint inhibitor (ICI) therapy has become a standard therapy in the treatment of advanced renal cell carcinomas (RCC). This has led to a proportional increase in the frequency of immune related adverse events (irAE), howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eb62de93cd884ddca142cb738b2bd6c
https://doi.org/10.1200/jco.2022.40.16_suppl.4530
https://doi.org/10.1200/jco.2022.40.16_suppl.4530